Na+/H+ exchanger-1 inhibitors decrease myocardial superoxide production via direct mitochondrial action

Journal of Applied Physiology

Volumn 105, Issue 6, 2008, Pages 1706-1713

  Garciarena, Carolina D ^a   Caldiz, Claudia I ^a   Correa, María V ^a   Schinella, Guillermo R ^a   Mosca, Susana M ^a   Chiappe De Cingolani, Gladys E ^a   Cingolani, Horacio E ^a   Ennis, Irene L ^a,b  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Mitochondria; Reactive oxygen species; Sodium hydrogen exchanger 1

Indexed keywords

ANGIOTENSIN II; BIIB 723; CARIPORIDE; EMD 87580; ENDOTHELIN 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; S6 KINASE; SODIUM PROTON EXCHANGE PROTEIN 1; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HEART MUSCLE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL;

ANGIOTENSIN II; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CALCIUM CHLORIDE; CATS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GUANIDINES; MITOCHONDRIA, HEART; MITOCHONDRIAL SWELLING; MYOCARDIUM; NADPH OXIDASE; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SODIUM-HYDROGEN ANTIPORTER; SULFONES; SUPEROXIDES;

EID: 57349164397     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.90616.2008     Document Type: Article

References (59)

1. 2+- and protein kinase C-dependent mechanism. Am J Physiol Heart Circ Physiol 280: H1528-H1536, 2001.
2. Akao M, O'Rourke B, Kusuoka H, Teshima Y, Jones SP, Marban E. Differential actions of cardioprotective agents on the mitochondrial death pathway. Circ Res 92: 195-202, 2003.
3. Amin JK, Xiao L, Pimental DR, Pagano PJ, Singh K, Sawyer DB, Colucci WS. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 33: 131-139, 2001.
4. i load after ischemia and improves function in intact hearts. Am J Physiol Heart Circ Physiol 281: H2398-H2409, 2001.
5. Avkiran M, Haworth RS. Regulatory effects of G protein-coupled receptors on cardiac sarcolemmal Na+/H+ exchanger activity: signalling and significance. Cardiovasc Res 57: 942-952, 2003.
6. +-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure. Cardiovasc Res 65: 83-92, 2005.
7. Baines CP, Song CX, Zheng YT, Wang GW, Zhang J, Wang OL, Guo Y, Bolli R, Cardwell EM, Ping P. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 92: 873-880, 2003.
8. Bolli R, Zughaib M, Li XY, Tang XL, Sun JZ, Triana JF, McCay PB. Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial "stunning." J Clin Invest 96: 1066-1084, 1995.
9. Brandes RP. Triggering mitochondrial radical release: a new function for NADPH oxidases. Hypertension 45: 847-848, 2005.
10. Caldiz CI, Garciarena CD, Dulce RA, Novaretto LP, Yeves AM, Ennis IL, Cingolani HE, Chiappe de Cingolani G, Perez NG. Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium. J Physiol 584: 895-905, 2007.
11. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, Hare JM. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104: 2407-2411, 2001.
12. Cingolani HE, Ennis IL. Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy. Circulation 115: 1090-1100, 2007.
13. Cingolani HE, Ennis IL, Mosca SM. NHE-1 and NHE-6 activities: ischemic and reperfusion injury. Circ Res 93: 694-696, 2003.
14. Cingolani HE, Perez NG, Aiello EA, de Hurtado MC. Intracellular signaling following myocardial stretch: an autocrine/paracrine loop. Regul Peptides 128: 211-220, 2005.
15. Cingolani HE, Plastino JA, Escudero EM, Mangal B, Brown J, Perez NG. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study. J Cardiac Fail 12: 491-498, 2006.
16. Cingolani HE, Villa-Abrille MC, Cornelli M, Nolly A, Ennis IL, Garciarena C, Suburo AM, Torbidoni V, Correa MV, Camilionde Hurtado MC, Aiello EA. The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species. Hypertension 47: 727-734, 2006.
17. Cohen MV, Yang XM, Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115: 1895-1903, 2007.
18. Dell'Italia LJ, Meng QC, Balcells E, Wei CC, Palmer R, Hageman GR, Durand J, Hankes GH, Oparil S. Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest 100: 253-258, 1997.
19. Dikalov S, Griendling KK, Harrison DG. Measurement of reactive oxygen species in cardiovascular studies. Hypertension 49: 717-727, 2007.
20. Downey JM, Cohen MV. Free radicals in the heart: friend or foe? Exp Rev Cardiovasc Ther 6: 589-591, 2008.
21. Duda M, Konior A, Klemenska E, Beresewicz A. Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart. J Mol Cell Cardiol 42: 400-410, 2007.
22. + exchanger inhibition at the onset of reperfusion decreases myocardial infarct size: role of reactive oxygen species. Cardiovasc Pathol 15: 179-184, 2006.
23. Griendling KK. Novel NAD(P)H oxidases in the cardiovascular system. Heart (British Cardiac Society) 90: 491-493, 2004.
24. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res 61: 372-385, 2004.
25. + exchange inhibitor, on the ion transport of myocardial mitochondria. Mol Cell Biochem 219: 83-90, 2001.
26. + kinetics in preconditioned rat heart. Circ Res 88: 1176-1182, 2001.
27. + exchanger isoform 1 inhibition is mediated by reduced mitogen-activated protein kinase activation secondary to improved mitochondrial integrity and decreased generation of mitochondrial-derived reactive oxygen species. J Pharmacol Exp Ther 317: 1036-1043, 2006.
28. Javadov S, Choi A, Rajapurohitam V, Zeidan A, Basnakian AG, Karmazyn M. NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition. Cardiovasc Res 77: 416-424, 2008.
29. Javadov S, Huang C, Kirshenbaum L, Karmazyn M. NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat. J Mol Cell Cardiol 38: 135-143, 2005.
30. Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem 20: 1-22, 2007.
31. + exchange. The effect of amiloride analogues. Biochim Biophys Acta 944: 383-390, 1988.
32. 2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am J physiol Heart Circ Physiol 290: H2024-H2034, 2006.
33. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Abe Y. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension 45: 438-444, 2005.
34. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Suzuki T, Maeta H, Abe Y. Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 45: 860-866, 2005.
35. Lassegue B, Griendling KK. Reactive oxygen species in hypertension; an update. Am J Hypertens 17: 852-860, 2004.
36. Li L, Fink GD, Watts SW, Northcott CA, Galligan JJ, Pagano PJ, Chen AF. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 107: 1053-1058, 2003.
37. Li Q, Bolli R, Qiu Y, Tang XL, Murphree SS, French BA. Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation 98: 1438-1448, 1998.
38. Minhas KM, Saraiva RM, Schuleri KH, Lehrke S, Zheng M, Saliaris AP, Berry CE, Barouch LA, Vandegaer KM, Li D, Hare JM. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy. Circ Res 98: 271-279, 2006.
39. + exchange inhibition against ischemia/reperfusion injury. J Am Coll Cardiol 37: 957-963, 2001.
40. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88: 581-609, 2008.
41. Myers ML, Farhangkhoee P, Karmazyn M. Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Cardiovasc Res 40: 290-296, 1998.
42. Nishikimi M, Appaji N, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 46: 849-854, 1972.
43. + exchanger. J Biol Chem 273: 6951-6959, 1998.
44. Petronilli V, Penzo D, Scorrano L, Bernardi P, Di Lisa F. The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J Biol Chem 276: 12030-12034, 2001.
45. Pimentel DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J, Baliga R, Wang J, Siwik DA, Singh K, Pagano P, Colucci WS, Sawyer DB. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 89: 453-460, 2001.
46. 2+ overload in NRVM involves ERK1/2 MAP kinases: role for an NHE-1-dependent pathway. Am J Physiol Heart Circ Physiol 283: H598-H605, 2002.
47. Ruiz-Meana M, Garcia-Dorado D, Pina P, Inserte J, Agullo L, Soler-Soler J. Cariporide preserves mitochondrial proton gradient and delays ATP depletion in cardiomyocytes during ischemic conditions. Am J Physiol Heart Circ Physiol 285: H999-H1006, 2003.
48. + exchange in neonatal rat cardiac myocytes. Circ Res 82: 1053-1062, 1998.
49. Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart (British Cardiac Society) 93: 903-907, 2007.
50. + exchange by hydrogen peroxide in adult rat ventricular myocytes. Cardiovasc Res 53: 470-480, 2002.
51. + exchange inhibitor, inhibits the mitochondrial death pathway. Circulation 108: 2275-2281, 2003.
52. Tissier R, Berdeaux A, Ghaleh B, Couvreur N, Krieg T, Cohen MV, Downey JM. Making the heart resistant to infarction: how can we further decrease infarct size? Front Biosci 13: 284-301, 2008.
53. +-transport also inhibit carbonic anhydrase (Abstract). FASEB J 21: 916.10, 2007.
54. 2 in rat cardiac myocytes. Am J Physiol Cell Physiol 281: C1542-C1550, 2001.
55. 1- adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol 282: C926-C934, 2002.
56. Zhang DX, Chen YF, Campbell WB, Zou AP, Gross GJ, Li PL. Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ Res 89: 1177-1183, 2001.
57. Zhang GX, Lu XM, Kimura S, Nishiyama A. Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation. Cardiovasc Res 76: 204-212, 2007.
58. Zhang M, Kho AL, Anilkumar N, Chibber R, Pagano PJ, Shah AM, Cave AC. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation 113: 1235-1243, 2006.
59. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 192: 1001-1014, 2000.